The federal government is funding a monumental project to map 200,000 human genomes in an effort to understand the genetic causes of common diseases such as cardiovascular disease, diabetes, epilepsy and autism.
Jan 18, 2016
0
45
Tiny vials of recently repaired blood cells are thriving in a Stanford incubator, proof that a powerful new gene-editing technique is fixing errant genes that cause so much human suffering.
Jan 12, 2016
0
20
An international team of researchers has established the cause of rare syndrome consistent with Fanconi Anemia: a de novo mutation in a so called RAD51 gene, which is responsible for repairing damages in the DNA. Fanconi ...
Dec 22, 2015
0
0
An established drug for recurrent multiple myeloma might effectively be repurposed to improve the survival and day-to-day lives of patients with devastating sickle cell disease, according to revealing new research by a Feinstein ...
Dec 17, 2015
0
306
In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin
Dec 16, 2015
0
2
A new study describes the development of pediatric pain measures for a National Institutes of Health Initiative aimed at helping doctors better evaluate and therefore better treat children who cope with chronic pain. Based ...
Dec 9, 2015
0
2
Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American ...
Dec 7, 2015
0
11
(HealthDay)—For children with lactic acidosis due to severe anemia, transfusion with longer-storage red blood cell (RBC) units is noninferior to shorter-storage RBC units, according to a study published online Dec. 5 in ...
Dec 7, 2015
0
1
(HealthDay)—Head lice infestation could cause iron deficiency anemia in the absence of any other cause, according to a case report published online Nov. 5 in BMJ Case Reports.
Nov 17, 2015
0
11
Cunlin Wang, M.D., Ph.D., of the U.S. Food and Drug Administration, Silver Spring, Md., and colleagues studied recipients of intravenous (IV) iron (n = 688,183) enrolled in the fee-for-service Medicare program from January ...
Nov 17, 2015
0
5
